The US FDA has refused to approve Astellas’ stomach cancer drug
Japan’s Astellas Pharma said the US Food and Drug Administration has refused to approve its experimental drug to treat a type of stomach cancer, citing problems with a third-party manufacturer.
POPULAR POSTS
Earthquakes and emissions undermine the idea of carbon storage in Texas
December 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
December 17, 2024
“Gilmore Girls” airs for a second season on Hulu
December 17, 2024
LIVE STREAM